United States Biotechnology & Medical Research

Ligand Pharmaceuticals Inc (LGND)

Track

Over the past 90 days, Ligand Pharmaceuticals Inc. has seen 45 insider trading transactions, all of which were sales totaling approximately $18.64 million. Notably, CLO and Secretary Andrew Reardon has been active with multiple planned sales. These transactions occurred amid a 36.7% stock price increase, with the stock currently trading near its 52-week high.
Ticker: LGND Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ligand Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 3 Aug 2026
Value US$2,235,794.49 | Price 300.34 | Shares 57,092 (-7.1%)
Planned sale 3 Aug 2026
Value US$4,286,641.41 | Price 230.01 | Shares 82,085 (+21.1%)
Planned sale 3 Aug 2026
Value US$100,000.00 | Price 290.60 | Shares 1,000 (-0.5%)
Planned sale 3 Aug 2026
Value US$100,000.00 | Price 289.80 | Shares 1,000 (-1.2%)
Planned sale 3 Aug 2026
Value US$100,000.00 | Price 288.75 | Shares 1,000 (-0.8%)
Planned sale 3 Aug 2026
Value US$100,000.00 | Price 287.77 | Shares 1,000 (-2.7%)
Planned sale 3 Aug 2026
Value US$100,000.00 | Price 286.80 | Shares 1,000 (-2.2%)
Planned sale 3 Aug 2026
Value US$100,000.00 | Price 285.74 | Shares 1,000 (-0.3%)
Planned sale 3 Aug 2026
Value US$100,000.00 | Price 284.55 | Shares 1,000 (-0.1%)
Planned sale 3 Aug 2026
Value US$100,000.00 | Price 284.14 | Shares 1,000 (-0.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
57,092 -7.1%
300.34
US$2,235,794 		57,092 -7.1% 300.34 US$2,235,794
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
82,085 +21.1%
230.01
US$4,286,641 		82,085 +21.1% 230.01 US$4,286,641
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
90,561 +10.9%
76.79
US$4,695,614 		90,561 +10.9% 76.79 US$4,695,614
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,000 -1.2%
289.80
US$100,000 		1,000 -1.2% 289.80 US$100,000
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,000 -0.8%
288.75
US$100,000 		1,000 -0.8% 288.75 US$100,000
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,000 -2.7%
287.77
US$100,000 		1,000 -2.7% 287.77 US$100,000
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,000 -2.2%
286.80
US$100,000 		1,000 -2.2% 286.80 US$100,000
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,000 -0.3%
285.74
US$100,000 		1,000 -0.3% 285.74 US$100,000
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,000 -0.1%
284.55
US$100,000 		1,000 -0.1% 284.55 US$100,000
2026-08-04 2026-08-03 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,000 -0.2%
284.14
US$100,000 		1,000 -0.2% 284.14 US$100,000
2026-07-06 2026-07-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
600 -1.4%
317.15
US$190,291 		600 -1.4% 317.15 US$190,291
2026-07-06 2026-07-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
900 -2.1%
315.78
US$284,200 		900 -2.1% 315.78 US$284,200
2026-07-06 2026-07-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
100 -0.2%
314.58
US$31,458 		100 -0.2% 314.58 US$31,458
2026-07-06 2026-07-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
700 -1.6%
313.46
US$219,420 		700 -1.6% 313.46 US$219,420
2026-07-06 2026-07-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,081 -2.4%
312.28
US$337,573 		1,081 -2.4% 312.28 US$337,573
2026-07-06 2026-07-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,119 -2.4%
311.72
US$348,815 		1,119 -2.4% 311.72 US$348,815
2026-07-06 2026-07-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
104 -0.2%
310.20
US$32,261 		104 -0.2% 310.20 US$32,261
2026-07-06 2026-07-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
396 -0.9%
308.99
US$122,359 		396 -0.9% 308.99 US$122,359
2026-07-01 2026-07-01 PrS Proposed sale
2.3
ANDREW REARDON

Officer

Officer
10,000
316.09
US$3,160,900 		10,000 316.09 US$3,160,900
2026-06-18 2026-06-16 S Sale
3.9
Sabba Stephen L
Non-Executive Director
2,145 -6.0%
254.00
US$544,830 		2,145 -6.0% 254.00 US$544,830
2026-06-16 2026-06-16 PrS Proposed sale
3.9
STEPHEN L. SABBA

Director

Non-Executive Director
2,145
254.00
US$544,830 		2,145 254.00 US$544,830
2026-06-15 2026-06-12 S Sale
1.1
Haas Jason
Non-Executive Director
3,461 -41.0%
256.08
US$886,286 		3,461 -41.0% 256.08 US$886,286
2026-06-15 2026-06-12 S Sale
1.1
Haas Jason
Non-Executive Director
3,000 -26.2%
255.01
US$765,034 		3,000 -26.2% 255.01 US$765,034
2026-06-12 2026-06-12 PrS Proposed sale
1.1
JASON HAAS

Director

Non-Executive Director
6,461
256.00
US$1,654,016 		6,461 256.00 US$1,654,016
2026-06-12 2026-06-11 S Sale
2.4
Aryeh Jason
Non-Executive Director
4,500 -4.2%
250.00
US$1,125,000 		4,500 -4.2% 250.00 US$1,125,000
2026-06-11 2026-06-11 PrS Proposed sale
2.4
Aryeh Jason

Director

Non-Executive Director
4,500
249.97
US$1,124,880 		4,500 249.97 US$1,124,880
2026-06-12 2026-06-10 S Sale
3.2
LAMATTINA JOHN L
Non-Executive Director
3,405 -11.2%
251.62
US$856,752 		3,405 -11.2% 251.62 US$856,752
2026-06-12 2026-06-10 S Sale
3.2
LAMATTINA JOHN L
Non-Executive Director
697 -2.2%
249.53
US$173,924 		697 -2.2% 249.53 US$173,924
2026-06-12 2026-06-10 S Sale
3.2
LAMATTINA JOHN L
Non-Executive Director
232 -0.7%
248.11
US$57,562 		232 -0.7% 248.11 US$57,562
2026-06-12 2026-06-10 S Sale
3.2
LAMATTINA JOHN L
Non-Executive Director
257 -0.8%
247.22
US$63,536 		257 -0.8% 247.22 US$63,536
2026-06-12 2026-06-10 S Sale
2.4
Aryeh Jason
Non-Executive Director
500 -0.5%
250.00
US$125,000 		500 -0.5% 250.00 US$125,000
2026-06-10 2026-06-10 PrS Proposed sale
2.4
Aryeh Jason

Director

Non-Executive Director
500
249.96
US$124,980 		500 249.96 US$124,980
2026-06-10 2026-06-10 PrS Proposed sale
3.2
JOHN L LAMATTINA

Director

Non-Executive Director
4,519
250.88
US$1,133,711 		4,519 250.88 US$1,133,711
2026-06-10 2026-06-10 PrS Proposed sale
2.4
Aryeh Jason

Director

Non-Executive Director
5,000
249.35
US$1,246,750 		5,000 249.35 US$1,246,750
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
200 -0.5%
230.41
US$46,082 		200 -0.5% 230.41 US$46,082
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,216 -2.8%
229.47
US$279,033 		1,216 -2.8% 229.47 US$279,033
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
584 -1.3%
228.57
US$133,487 		584 -1.3% 228.57 US$133,487
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
400 -0.9%
226.78
US$90,712 		400 -0.9% 226.78 US$90,712
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,432 -3.2%
225.97
US$323,585 		1,432 -3.2% 225.97 US$323,585
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
677 -1.5%
225.20
US$152,459 		677 -1.5% 225.20 US$152,459
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
491 -1.1%
223.95
US$109,958 		491 -1.1% 223.95 US$109,958
2026-05-14 2026-05-13 S Sale
3.4
KOZARICH JOHN W
Non-Executive Director
1,575 -3.6%
223.50
US$352,012 		1,575 -3.6% 223.50 US$352,012
2026-05-13 2026-05-13 PrS Proposed sale
3.4
JOHN KOZARICH

Director

Non-Executive Director
1,575
223.50
US$352,012 		1,575 223.50 US$352,012
2026-05-14 2026-05-12 S Sale
3.4
KOZARICH JOHN W
Non-Executive Director
459 -1.1%
224.00
US$102,816 		459 -1.1% 224.00 US$102,816
2026-05-12 2026-05-12 PrS Proposed sale
3.4
JOHN KOZARICH

Director

Non-Executive Director
459
224.00
US$102,816 		459 224.00 US$102,816
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
116 -0.3%
234.09
US$27,154 		116 -0.3% 234.09 US$27,154
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
105 -0.2%
232.57
US$24,420 		105 -0.2% 232.57 US$24,420
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
165 -0.4%
231.87
US$38,258 		165 -0.4% 231.87 US$38,258
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
1 -0.0%
229.87
US$230 		1 -0.0% 229.87 US$230
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
80 -0.2%
227.37
US$18,189 		80 -0.2% 227.37 US$18,189
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
800 -1.9%
234.02
US$187,214 		800 -1.9% 234.02 US$187,214
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,420 -3.3%
232.92
US$330,749 		1,420 -3.3% 232.92 US$330,749
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
780 -1.8%
232.04
US$180,991 		780 -1.8% 232.04 US$180,991
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
370 -0.8%
230.87
US$85,422 		370 -0.8% 230.87 US$85,422
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
98 -0.2%
229.71
US$22,511 		98 -0.2% 229.71 US$22,511
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
932 -2.0%
228.75
US$213,198 		932 -2.0% 228.75 US$213,198
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
600 -1.3%
227.45
US$136,470 		600 -1.3% 227.45 US$136,470
2026-05-01 2026-05-01 PrS Proposed sale
3.4
KOZARICH JOHN W

Director

Non-Executive Director
467
229.87
US$107,349 		467 229.87 US$107,349
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
337 -0.8%
204.50
US$68,917 		337 -0.8% 204.50 US$68,917
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
337 -0.8%
204.50
US$68,917 		337 -0.8% 204.50 US$68,917
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
963 -2.3%
203.22
US$195,703 		963 -2.3% 203.22 US$195,703
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
963 -2.3%
203.22
US$195,703 		963 -2.3% 203.22 US$195,703
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
700 -1.6%
201.90
US$141,328 		700 -1.6% 201.90 US$141,328
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
700 -1.6%
201.90
US$141,328 		700 -1.6% 201.90 US$141,328
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,238 -2.8%
200.94
US$248,767 		1,238 -2.8% 200.94 US$248,767
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,238 -2.8%
200.94
US$248,767 		1,238 -2.8% 200.94 US$248,767
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,302 -2.8%
199.72
US$260,038 		1,302 -2.8% 199.72 US$260,038
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,302 -2.8%
199.72
US$260,038 		1,302 -2.8% 199.72 US$260,038
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
460 -1.0%
198.85
US$91,471 		460 -1.0% 198.85 US$91,471
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
460 -1.0%
198.85
US$91,471 		460 -1.0% 198.85 US$91,471
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
159 -0.4%
204.26
US$32,478 		159 -0.4% 204.26 US$32,478
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
159 -0.4%
204.26
US$32,478 		159 -0.4% 204.26 US$32,478
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
43 -0.1%
202.91
US$8,725 		43 -0.1% 202.91 US$8,725
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
43 -0.1%
202.91
US$8,725 		43 -0.1% 202.91 US$8,725
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
79 -0.2%
202.42
US$15,991 		79 -0.2% 202.42 US$15,991
Explore more

More insider trading research around Ligand Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America